Adaptimmune Therapeutics
ADAP
#8447
Rank
ยฃ0.12 B
Marketcap
ยฃ0.48
Share price
0.82%
Change (1 day)
22.19%
Change (1 year)

Market capitalization of Adaptimmune Therapeutics (ADAP)

Market cap: ยฃ0.12 Billion

As of December 2024 Adaptimmune Therapeutics has a market cap of ยฃ0.12 Billion. This makes Adaptimmune Therapeutics the world's 8447th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptimmune Therapeutics from 2015 to 2024

End of year Market Cap

Year Marketcap Change
2024ยฃ0.12 B-12.92%
2023ยฃ0.14 B-28.5%
2022ยฃ0.19 B-54.44%
2021ยฃ0.43 B-29.1%
2020ยฃ0.61 B536.01%
2019ยฃ96.24 M-79.68%
2018ยฃ0.47 B2.3%
2017ยฃ0.46 B99.31%
2016ยฃ0.23 B-59.67%
2015ยฃ0.57 B

End of Day market cap according to different sources

On Dec 22nd, 2024 the market cap of Adaptimmune Therapeutics was reported to be:

ยฃ0.12 Billion
by Nasdaq info icon info icon
ยฃ0.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ยฃ1.10 B 800.36%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ31.69 M-74.26%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.65 B 434.72%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
ยฃ7.56 B 6,042.07%๐Ÿ‡บ๐Ÿ‡ธ USA